Genetically encoded fluorescent biosensors allow researchers to see how products form in real time in microorganisms, and to test billions of candidates at a time
The model, presented in the journal eLife, uses an approach that could lead to accurate predictions of the interactions between novel drugs and their targets, helping to reduce the cost of drug discovery